Overview on Remdesivir

Sahil Surendrakumar Shambharkar

Abstract: Remdesiviris a broad range anti viral drug primarily discovered for the treatment for hepatitis C and respiratory syncytial virus (RSV), later used in the treatment of ebola and now is being used in the treatment of covid-spectrum antiviral agent that has previously demonstrated antiviral activity against filoviruses (ebola viruses, marburgvirus), coronaviruses (SARS-COV, MERS-CO-V, SARS-COV-2), paramyxoviruses (parainfluenza type iii virus, nipah virus, hendra virus, measles, and mumps virus), and pnemoviridae (respiratory syncytial virus).

Keywords: remdesivir, GS-441524, SARS-COV-2, COVID-19, nucleoside triphosphate, RNA dependant RNA polymerase, ebola

How to Cite?: Sahil Surendrakumar Shambharkar, "Overview on Remdesivir", Volume 10 Issue 6, June 2021, International Journal of Science and Research (IJSR), Pages: 1344-1349, https://www.ijsr.net/getabstract.php?paperid=MR21620233610, DOI: https://dx.doi.org/10.21275/MR21620233610

Download Citation: APA | MLA | BibTeX | EndNote | RefMan